(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2... grant of $2.25 million has been awarded to the Ke... Study of Traumatic Stress-Summa Health System // ...curity Studies by National Institute of Mental Hea...ts effect on mental health of the people. The fou...
...esearchers have explained that on altering the imm...ey could develop a therapeutic treatment for AIDS.... have claimed that they are of the belief that if ...ne system cells through a laboratory version of bo...
...he National Heart, Lung, and Blood Institute (NHLB...issued a new publication in order to ensure that p...ysical activity is thought to help maintain a heal...lts do not get the necessary exercise. "Your Guid...
...ndia declared itself ‘‘avian influenza free countr...the February/March outbreak in Maharashtra and Guj...an influenza free country and a final report in th...isation of Animal Health yesterday," said a statem...
Other Medicine News:Health News:Activated T-Cells Could Help In The Battle Against HIV 2Health News:Activated T-Cells Could Help In The Battle Against HIV 3Health News:Guide For A Healthy Heart 2(Date:9/4/2008)... Ala., Sept. 4 /- Southern Research I...tes of Health (NIH) has selected,the organization ...ries,Probe Production Center Network (MLPCN). The ...rt of the Molecular Libraries Program which is,des...knowledge of the human,genome and validate future ...
(Date:9/4/2008)...ated Survival Data for Ipilimumab to be Presented,...-- Medarex, Inc.,(Nasdaq: MEDX ) announced today ...vestigational anti-CTLA-4 antibody, in melanoma ar...the 33rd Congress of the European Society,for Medi...08 in Stockholm.,Many of the following abstracts w...
(Date:9/4/2008)...ements Remain on Schedule with Two Abstracts Accep...Release in November 2008, BRIDGEWATER, N.J., Sept..., a specialty pharmaceutical company focused on th...e, today announced the appointment of,Peter L. Gar... Peter Garrambone,s career includes more than 50 ...
(Date:9/3/2008)...ina, Sept. 3 /- Simcere,Pha...turer and supplier of,branded generic pharmaceutic...iotech product Endu (also known as Endostar) in Ch...V clinical study., At the request of the SFDA, Si...er validate the safety and therapeutic efficacy of...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 1Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 2Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 3Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 4Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 5CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 114 1CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 114 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 114 3First finding of a metabolite in 1 sex only 119 1First finding of a metabolite in 1 sex only 119 2NanoMed Inc Spins Out of Zyvex Labs 128 1NanoMed Inc Spins Out of Zyvex Labs 128 2... , ,OTTAWA, Canada – March 7, 2007 – L... specializing in developing,advanced products rela...d “good cholesterol,” today announced ...ad product, CRD5. CRD5 is,being developed for the ...sults showed, to date, that CRD5 was safe and that...
...antly reduced the number of,new or enlarged lesion...esentation at upcoming medical meeting -, CAMBRIDG...wswire-FirstCall/ -- Biogen Idec, Inc. and PDL Bio...g CHOICE trial, a Phase 2,randomized, double-blin... primary endpoint in relapsing multiple sclerosis ...
Other Medicine Technology:Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 2Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 4Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 5...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: